Election petition: Every evidence pointed to Mahama’s victory - Asiedu Nketia tells judges

Election petition: Every evidence pointed to Mahama’s victory - Asiedu Nketia tells judges

-The EC, however, thought otherwise, declaring President Nana Akufo-Addo as the winner instead

-Former President Mahama has rejected the results as a sham and launched a petition at the Supreme Court aimed at having the results canceled

- Akufo-Addo defeated him by collecting 51.302% of the votes

Our manifesto: This is what YEN.com.gh believes in

Johnson Asiedu Nketia, one of the witnesses for John Mahama in the on-going election petition trial on Monday, February 1, 2021, maintained that “every evidence” pointed to the victory of the former president in the December 2020 presidential election.

Nketia made this remark after videotapes of him and other functionaries of the National Democratic Congress (NDC) including Mahama were played during the trial hearing.

Election petition: Every evidence pointed to Mahama’s victory - Asiedu Nketia tells judges
Image credit: John Dramani Mahama
Source: Facebook

The party functionaries including the former president claimed victory in the 2020 general elections, contrary to the figures announced by the Electoral Commission (EC).

“My Lords, I implied that I expected President Mahama to win the elections. Every evidence was pointing at president Mahama’s victory,” Nketia told the Court.

Read also

Election petition: Figures were just thrown out to give Akufo-Addo victory - Tsatsu Tsikata

Mahama on Wednesday, December 30, 2020, filed a petition before the Apex Court to challenge the outcome of the 2020 presidential race.

He wants a rerun to be conducted between him and President Akufo-Addo.

Akufo-Addo defeated him in the election by collecting 51.302% of the votes cast against the latter’s 47.359%.

The votes difference between the two candidates stood at 517, 231, representing a four percentage point, one of the highest since 1996.

In other news, a herbal medicine, Cryptolepis sanguinolenta, has been approved for a clinical trial in Ghana for the treatment of COVID-19, signaling a breakthrough in the fight against the virus in the West African country.

Known locally as ‘Nibima’, Cryptolepis sanguinolenta’s approval for the trial was announced on Monday, February 1, 2021, by the Food and Drugs Authority (FDA).

This comes at the time the country is reeling under the devastating nature of the scourge.

Read also

Supreme Court dismisses Mahama's request for additional ground for review application

Ghana recorded its first case of the virus on March 12, 2020, from two people who arrived in the country—a Ghanaian and a Norwegian national.

Ghana has since the inception of January witnessed an astronomical surge in case count. Active cases stand at 5,358.

So far, 416 people have died from the deadly contagion with 170 and 44 persons in severe and critical conditions respectively.

In a communiqué issued and signed by the CEO of the FDA and sighted by YEN.com.gh, the clinical trials will be conducted at two locations.

The herbal medicine developed by the School of Public Health at the Kwame Nkrumah University of Science and Technology (KNUST) was submitted to the FDA for the clinical trial in September 2020 and approval was granted in January 2021.

Enjoy reading our stories?

Join YEN.com.gh's Telegram channel!

Download YEN's news app on Google Play now and stay up-to-date with major Ghana news!

Read also

Supreme Court strikes out Mahama’s stay of proceedings application

Source: YEN.com.gh

Online view pixel